Skip to main content
SpringerLink
Log in

Imaging of matrix metalloproteinase activation and left ventricular remodeling

  • Nuclear Cardiology
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Although left ventricular (LV) remodeling may be adaptive in early phases of cardiac injury, continued remodeling is a pathologic process that is associated with poor prognosis and diminished cardiac function. Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes involved in the degradation of myocardial extracellular proteins and have been implicated in adverse cardiac remodeling. There is a growing body of literature that supports the role of specific MMPs in cardiac remodeling in both animal models and clinical studies. Conventional imaging of physiologic indices, such as perfusion and function, have been used to monitor LV remodeling. Recently, the potential, advantage of targeted imaging of MMPs has been demonstrated, particularly if this is linked with physiologic imaging.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Cohn JN, Ferrari R, Sharpe N:Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.J Am Coll Cardiol 2000,35:569–582.

    Article  PubMed  CAS  Google Scholar 

  2. Of importance Lindsey ML:MMP induction and inhibition in myocardial infarction.Heart Fail Rev 2004,9:7–19. This is an excellent review article that introduces MMP background knowledge as well as an overview of research in MMPs and LV remodeling.

    Article  PubMed  CAS  Google Scholar 

  3. Cleutjens JP, Blankesteijn WM, Daemen MJ, Smits JF:The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions Cardiovasc Res 1999,44:232–241.

    Article  PubMed  CAS  Google Scholar 

  4. Sutton MG, Sharpe N:Left ventricular remodeling after myocardial infarction: pathophysiology and therapy.Circulation 2000,101:2981–2988.

    PubMed  CAS  Google Scholar 

  5. Bolognese L, Neskovic AN, Parodi G, et al.:Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications.Circulation 2002,106:2351–2357.

    Article  PubMed  Google Scholar 

  6. Wong SP, French JK, Lydon AM, et al.:Relation of left ventricular sphericity to 10-year survival after acute myocardial infarction.Am J Cardiol 2004,94:1270–1275.

    Article  PubMed  Google Scholar 

  7. Nagase H, Woessner JF Jr:Matrix metalloproteinases.J Biol Chem 1999,274:21491–21494.

    Article  PubMed  CAS  Google Scholar 

  8. Emonard H, Grimaud JA:Matrix metalloproteinases. A review.Cell Mol Biol (Noisy-le-grand) 1990,36:131–153.

    CAS  Google Scholar 

  9. Menshikov M, Torosyan N, Elizarova E, et al.:Urokinase induces matrix metalloproteinase-9/gelatinase B expression in THP-1 monocytes via ERK1/2 and cytosolic phospholipase A 2 activation and eicosanoid production.J Vasc Res 2006,43:482–490.

    Article  PubMed  CAS  Google Scholar 

  10. Heymans S, Pauschinger M, De Palma A, et al.:Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.Circulation 2006,114:565–573.

    Article  PubMed  CAS  Google Scholar 

  11. Stempien-Otero A, Plawman A, Meznarich J, et al.:Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator.J Biol Chem 2006,281:15345–15351.

    Article  PubMed  CAS  Google Scholar 

  12. Spinale FG:Matrix metalloproteinases: regulation and dysregulation in the failing heart.Circ Res 2002,90:520–530.

    Article  PubMed  CAS  Google Scholar 

  13. Creemers EE, Davis JN, Parkhurst AM, et al.:Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice.Am J Physiol Heart Circ Physiol 2003,284:H364-H371.

    PubMed  CAS  Google Scholar 

  14. Ducharme A, Frantz S, Aikawa M, et al.:Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction.J Clin Invest 2000,106:55–62.

    Article  PubMed  CAS  Google Scholar 

  15. Chancey AL, Brower GL, Peterson JT, Janicki JSEffects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload.Circulation 2002,105:1983–1988.

    Article  PubMed  CAS  Google Scholar 

  16. Rohde LE, Ducharme A, Arroyo LH, et al.:Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice.Circulation 1999,99:3063–3070.

    PubMed  CAS  Google Scholar 

  17. yarbrough WM, Mukherjee R, et al.:Selective targeting of matrix metalloproteinase inhibition in post-infarction myocardial remodeling.J Cardiovasc Pharmacol 2006,47:228–235.

    Article  PubMed  Google Scholar 

  18. Anversa P, Beghi C, Kikkawa Y, Olivetti G:Myocardial response to infarction in the rat. Morphometric measurement of infarct size and myocyte cellular hypertrophy.Am J Pathol 1985,118:484–492.

    PubMed  CAS  Google Scholar 

  19. Of importance Gallagher G, Menzie S, Huang Y, et al.:Regional cardiac dysfunction is associated with specific alterations in inflammatory cytokines and matrix metalloproteinases after acute myocardial infarction in sheep.Basic Res Cardiol 2007,102:63–72. A review article that summarizes the timeline of MMP expression with the stages of myocardial remodeling.

    Article  PubMed  CAS  Google Scholar 

  20. Vanhoutte D, Schellings M, Pinto Y, Heymans S:Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window.Cardiovasc Res 2006,69:604–613.

    Article  PubMed  CAS  Google Scholar 

  21. Lindsey M, Wedin K, Brown MD, et al.:Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion.Circulation 2001,103:2181–2187.

    PubMed  CAS  Google Scholar 

  22. Mukherjee R, Mingoia JT, Bruce JA, et al.:Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription following myocardial infarction.Am J Physiol Heart Circ Physiol 2006,291:H2216–28.

    Article  PubMed  CAS  Google Scholar 

  23. Hojo Y, Ikeda U, Ueno S, et al.:Expression of matrix metalloproteinases in patients with acute myocardial infarction.Jpn Circ J 2001,65:71–75.

    Article  PubMed  CAS  Google Scholar 

  24. Kai H, Ikeda H, Yasukawa H, et al.:Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes.J Am Coll Cardiol 1998,32:368–372.

    Article  PubMed  CAS  Google Scholar 

  25. Matsunaga T, Abe N, Kameda K, et al.:Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarction.Int J Cardiol 2005,105:203–208.

    Article  PubMed  Google Scholar 

  26. Squire IB, Evans J, Ng LL, et al.:Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction.J Card Fail 2004,10:328–333.

    Article  PubMed  CAS  Google Scholar 

  27. Sundstrom J, Evans JC, Benjamin EJ, et al.:Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study.Circulation 2004,109:2850–2856.

    Article  PubMed  Google Scholar 

  28. Sundstrom J, Evans JC, Benjamin EJ, et al.:Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart study.Eur Heart J 2004,25:1509–1516.

    Article  PubMed  CAS  Google Scholar 

  29. Soejima H, Ogawa H, Sakamoto T, et al.:Increased serum matrix metalloproteinase-1 concentration predicts advanced left ventricular remodeling in patients with acute myocardial infarction.Circ J 2003,67:301–304.

    Article  PubMed  CAS  Google Scholar 

  30. Thomas CV, Coker ML, Zellner JL, et al.:Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.Circulation 1998,97:1708–1715.

    PubMed  CAS  Google Scholar 

  31. Of major importance Webb CS, Bonnema DD, Ahmed SH, et al.:Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction. Relation to left ventricular remodeling.Circulation 2006,114:1020–1027. A clinical study that relates serial serum MMP measurements with measures of LV geometry.

    Article  PubMed  CAS  Google Scholar 

  32. Bradham WS, Gunasinghe H, Holder JR, et al.:Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive cardiomyopathy.J Am Coll Cardiol 2002,40:2165–2173.

    Article  PubMed  CAS  Google Scholar 

  33. Kaden JJ, Dempfle CE, Sueselbeck T, et al.:Time-dependent changes in the plasma concentration of matrix metalloproteinase 9 after acute myocardial infarction.Cardiology 2003,99:140–144.

    Article  PubMed  CAS  Google Scholar 

  34. Thakur M, Lentle BC:Report of a summit on molecular imaging.Am J Roentgenol 2006,186:297–299.

    Article  Google Scholar 

  35. Patel AD, Iskandrian AE:MIBG imaging.J Nucl Cardiol 2002,9:75.

    Article  PubMed  Google Scholar 

  36. Bax JJ, van der Wall EE, Harbinson M:Radionuclide techniques for the assessment of myocardial viability and hibernation.Heart 2004,90(Suppl 5):v26-v33.

    Article  PubMed  Google Scholar 

  37. Bremer C, Tung CH, Weissleder R:In vivo molecular target assessment of matrix metalloproteinase inhibition.Nat Med 2001,7:743–748.

    Article  PubMed  CAS  Google Scholar 

  38. Elena ID, James PQ:Matrix metalloproteinases and tumor metastasis.Cancer Metastasis Rev 2006,V25:9.

    Article  Google Scholar 

  39. Schafers M, Riemann B, Kopka K, et al.:Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo.Circulation 2004,109:2554–2559.

    Article  PubMed  Google Scholar 

  40. Funayama H, Ishikawa SE, Kubo N, et al.:Increases in interleukin-6 and matrix metalloproteinase-9 in the infarct-related coronary artery of acute myocardial infarction.Circ J 2004,68:451–454.

    Article  PubMed  CAS  Google Scholar 

  41. Higo S, Uematsu M, Yamagishi M, et al.:Elevation of plasma matrix metalloproteinase-9 in the culprit coronary artery in patients with acute myocardial infarction: clinical evidence from distal protection.Circ J 2005,69:1180–1185.

    Article  PubMed  CAS  Google Scholar 

  42. Bertsch T, Sueselbeck T, Wolpert C, et al.:Time course of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients presenting with acute coronary syndrome.Clin Chem Lab Med 2005,43:660–663.

    Article  PubMed  CAS  Google Scholar 

  43. Chen J, Tung CH, Allport JR, et al.:Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction.Circulation 2005,111:1800–1805.

    Article  PubMed  CAS  Google Scholar 

  44. Of major importance Su H, Spinale FG, Dobrucki LW, et al.:Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling.Circulation 2005,112:3157–3167. This is the first paper to demonstrate serial in vivo imaging of MMPs in the myocardium.

    Article  PubMed  CAS  Google Scholar 

  45. McAteer J, Song J, Dobrucki LW, et al.:Targeted radiotracer imaging of myocardial matrix metalloproteinase activity post-myocardial infarction [abstract].Circulation 2005,112:II:761.

    Google Scholar 

  46. Sahul Z, Song J, McAteer J, et al.:Quantification of in-vivo matrix metalloproteinase activity and myocardial strain yield unique spatial temporal patterns in a porcine model of myocardial infarction [abstract].Circulation 2006,114:II:500.

    Google Scholar 

  47. Sahul Z, Song J, McAteer J, et al.:Non-invasive evaluation of regional myocardial strain and activation of matrix metalloproteinases [abstract].J Am Coll Cardiol 2006,47:114a-115a.

    Google Scholar 

  48. Kai H, Ikeda H, Yasukawa H, et al.:Peripheral blood levels of matrix metalloproteases-2 and-9 are elevated in patients with acute coronary syndromes.J Am Coll Cardiol 1998,32:368–372.

    Article  PubMed  CAS  Google Scholar 

  49. Hojo Y, Ikeda U, Ueno S, et al.:Expression of matrix metalloproteinases in patients with acute myocardial infarction.Jpn Circ J 2001,65:71–75.

    Article  PubMed  CAS  Google Scholar 

  50. Poulsen SH, Host NB, Jensen SE, Egstrup K:Relationship between serum amino-terminal propeptide of type III procollagen and changes of left ventricular function after acute myocardial infarction.Circulation 2000,101:1527–1532.

    PubMed  CAS  Google Scholar 

  51. Hayashi M, Tsutamoto T, Wada A, et al.:Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collage synthesis in patients with first anterior acute myocardial infarction.Circulation 2003,107:2559–2565.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nuclear Cardiology 3FMP, Yale University School of Medicine, PO Box 208017, 06520-8017, New Haven, CT, USA

    Albert J Sinusas MD

Authors
  1. Grace Chung BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Albert J Sinusas MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Albert J Sinusas MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chung, G., Sinusas, A.J. Imaging of matrix metalloproteinase activation and left ventricular remodeling. Curr Cardiol Rep 9, 136–142 (2007). https://doi.org/10.1007/BF02938340

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02938340

Keywords

Search

Navigation